Quentin Van Thillo; Cedric Hermans/LinkedIn
Nov 7, 2025, 03:20
Insights on Rebalancing Agents in Hemophilia from Cédric Hermans and Quentin Van Thillo
World Federation of Hemophilia (WFH) shared on LinkedIn:
”Rebalancing agents are reshaping hemophilia treatment—but key questions remain.
What do we know, where are the uncertainties, and how do we move forward responsibly?”
Read the full article in Haematologica.
Article: Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties
Authors: Quentin Van Thillo, Cédric Hermans
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke